Literature DB >> 31050819

Fulminant type 1 diabetes: The clinical and continuous glucose monitoring characteristics in Chinese patients.

Lingwen Ying1, Xiaojing Ma1, Jingyi Lu1, Wei Lu1, Wei Zhu1, Robert A Vigersky2,3, Weiping Jia1, Yuqian Bao1, Jian Zhou1.   

Abstract

The purpose of the current study was to investigate the clinical characteristics of fulminant type 1 diabetes mellitus (FT1DM) in Chinese patients and to further determine their glycaemic profiles through continuous glucose monitoring (CGM). Thirty subjects who were diagnosed with FT1DM according to the 2012 JDS criteria were enrolled. Clinical characteristics were compared to those reported in Japanese FT1DM. All subjects received retrospective CGM for 3 days after being converted to subcutaneous insulin injection therapy. Chinese FT1DM patients presented with a shorter duration of symptoms (2.84 ± 2.42 days vs 4.4 ± 3.1 days, P < 0.01), worse islet function (fasting C-peptide, 0.09 ± 0.11 ng/mL vs 0.30 ± 0.21 ng/mL; 2-hour C-peptide, 0.13 ± 0.14 ng/mL vs 0.30 ± 0.30 ng/mL, both P < 0.01), lower prevalence of flu-like symptoms (46.7% vs 71.4%, P < 0.05), and a significantly higher GADA positive rate (23.3% vs 5.1%, P < 0.01) when compared with Japanese patients. The CGM results showed that the mean time in range (TIR) of FT1DM patients was 49.8 ± 22.1%, while mean amplitude of glycaemic excursion (MAGE) and standard deviations of sensor glucose (SDSG) were 7.58 ± 3.59 mmol/L and 3.19 ± 1.22 mmol/L, respectively, with nearly 1/3 participants coefficient of variation (CV) > 36% (all are male), suggesting a large glucose fluctuation. The female patients were further divided into pregnancy-related FT1DM (PF) and non-PF (NPF) subgroups (both n = 5), and we found that PF patients had a significantly higher TIR than NPF patients (77.0 ± 16.1% vs 41.0 ± 22.4%, P < 0.05). There were heterogeneities in the clinical characteristics of FT1DM patients, and the CGM results indicated a very low TIR and large glucose fluctuation which needs careful attention.
© 2019 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  continuous glucose monitoring; fulminant type 1 diabetes mellitus; glucose fluctuation; time in range

Mesh:

Year:  2019        PMID: 31050819     DOI: 10.1111/1440-1681.13099

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  3 in total

1.  Current clinical state of type 1 diabetes in Saitama prefecture.

Authors:  Yoichi Oikawa; Koshi Hashimoto; Kazuo Hara; Jiro Morimoto; Kazuyuki Namai; Akihiko Tanaka; Satoshi Tanaka; Akira Shimada
Journal:  Diabetol Int       Date:  2021-11-01

2.  Classic Type 1 Diabetes Mellitus and Fulminant Type 1 Diabetes Mellitus: Similarity and Discrepancy of Immunological Characteristics and Cytokine Profile.

Authors:  Lingwen Ying; Yong Zhang; Jun Yin; Yufei Wang; Wei Lu; Wei Zhu; Yuqian Bao; Jian Zhou
Journal:  Diabetes Metab Syndr Obes       Date:  2021-11-30       Impact factor: 3.168

3.  Serum 1,5-Anhydroglucitol to Glycated Albumin Ratio Can Help Early Distinguish Fulminant Type 1 Diabetes Mellitus from Newly Onset Type 1A Diabetes Mellitus.

Authors:  Lingwen Ying; Xiaojing Ma; Yun Shen; Jingyi Lu; Wei Lu; Wei Zhu; Yufei Wang; Yuqian Bao; Jian Zhou
Journal:  J Diabetes Res       Date:  2020-03-20       Impact factor: 4.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.